API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/drug-delivery/grifols-readies-us-eu-approval-push-blood-clot-treatment-after-phase-3-success
https://www.ema.europa.eu/documents/procedural-steps-after/raplixa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
https://www.ema.europa.eu/documents/public-statement/public-statement-raplixa-withdrawal-marketing-authorisation-european-union_en-0.pdf
https://www.ema.europa.eu/documents/product-information/raplixa-epar-product-information_en.pdf
https://www.pharmacompass.com/pdf/news/instituto-grifols-sa-veraseal-human-fibrinogen-human-thrombin-receives-approval-in-europe-1516426069.pdf